Tongue cancer laboratory findings: Difference between revisions
Simrat Sarai (talk | contribs) No edit summary |
No edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Tongue cancer}} | {{Tongue cancer}} | ||
{{CMG}}{{AE}}{{Simrat}} | {{CMG}}; {{AE}} {{Simrat}} {{MAD}} | ||
==Overview== | ==Overview== | ||
Laboratory findings consistent with the diagnosis of tongue cancer include reduced [[CBC]] levels, abnormal [[prothrombin time]] ([[PT]]), abnormal [[activated partial thromboplastin time]] ([[aPTT]]), and abnormal [[international normalized ratio]] ([[INR]]). | Laboratory findings consistent with the diagnosis of tongue cancer include reduced [[CBC]] levels, abnormal [[prothrombin time]] ([[PT]]), abnormal [[activated partial thromboplastin time]] ([[aPTT]]), and abnormal [[international normalized ratio]] ([[INR]]). | ||
==Laboratory findings== | ==Laboratory findings== | ||
A complete blood cell count is a useful general screen that helps the consulting internist establish if further testing is warranted. | A complete blood cell count is a useful general screen that helps the consulting internist establish if further testing is warranted. | ||
In a patient with a suspected bleeding diathesis, investigations may also include tests of [[prothrombin time]] ([[PT]]), [[activated partial thromboplastin time]] ([[aPTT]]), and [[international normalized ratio]] ([[INR]]). | In a patient with a suspected bleeding diathesis, investigations may also include tests of [[prothrombin time]] ([[PT]]), [[activated partial thromboplastin time]] ([[aPTT]]), and [[international normalized ratio]] ([[INR]]).<ref name="pmid20798709">{{cite journal| author=| title=Chip developed to diagnose oral cancer in ten minutes. | journal=Br Dent J | year= 2010 | volume= 209 | issue= 4 | pages= 155 | pmid=20798709 | doi=10.1038/sj.bdj.2010.730 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20798709 }}</ref> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 19:50, 5 December 2017
|
Tongue cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tongue cancer laboratory findings On the Web |
|
American Roentgen Ray Society Images of Tongue cancer laboratory findings |
|
Risk calculators and risk factors for Tongue cancer laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2] Mohammed Abdelwahed M.D[3]
Overview
Laboratory findings consistent with the diagnosis of tongue cancer include reduced CBC levels, abnormal prothrombin time (PT), abnormal activated partial thromboplastin time (aPTT), and abnormal international normalized ratio (INR).
Laboratory findings
A complete blood cell count is a useful general screen that helps the consulting internist establish if further testing is warranted. In a patient with a suspected bleeding diathesis, investigations may also include tests of prothrombin time (PT), activated partial thromboplastin time (aPTT), and international normalized ratio (INR).[1]
References
- ↑ "Chip developed to diagnose oral cancer in ten minutes". Br Dent J. 209 (4): 155. 2010. doi:10.1038/sj.bdj.2010.730. PMID 20798709.